APA (7th ed.) Citation

DR, G., EJ, C., W, Z., M, U., K, S., M, L., . . . EE, G. (2026). Targeted Delivery of a Potent STING Agonist Payload via an Antibody-Drug Conjugate Drives Robust Antitumor Activity in Preclinical Models. Molecular cancer therapeutics, 25(3), 457. https://doi.org/10.1158/1535-7163.MCT-25-0108

Chicago Style (17th ed.) Citation

DR, Gruber, et al. "Targeted Delivery of a Potent STING Agonist Payload via an Antibody-Drug Conjugate Drives Robust Antitumor Activity in Preclinical Models." Molecular Cancer Therapeutics 25, no. 3 (2026): 457. https://doi.org/10.1158/1535-7163.MCT-25-0108.

MLA (9th ed.) Citation

DR, Gruber, et al. "Targeted Delivery of a Potent STING Agonist Payload via an Antibody-Drug Conjugate Drives Robust Antitumor Activity in Preclinical Models." Molecular Cancer Therapeutics, vol. 25, no. 3, 2026, p. 457, https://doi.org/10.1158/1535-7163.MCT-25-0108.